| Code | Description | Claims | Beneficiaries | Total Paid |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,752 |
1,303 |
$83K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,188 |
914 |
$30K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
123 |
104 |
$12K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
246 |
193 |
$10K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
219 |
159 |
$7K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
141 |
105 |
$6K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
86 |
72 |
$4K |
| 87634 |
|
37 |
30 |
$3K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
73 |
54 |
$2K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
46 |
42 |
$2K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
1,108 |
634 |
$2K |
| 96127 |
|
328 |
186 |
$499.03 |
| 90648 |
|
39 |
28 |
$425.22 |
| T1502 |
Administration of oral, intramuscular and/or subcutaneous medication by health care agency/professional, per visit |
396 |
275 |
$408.00 |
| 90677 |
|
46 |
31 |
$394.20 |
| 90723 |
|
43 |
28 |
$354.78 |
| 90681 |
|
17 |
12 |
$157.68 |
| 96161 |
|
805 |
552 |
$41.14 |
| 97802 |
|
315 |
215 |
$2.00 |
| 96160 |
|
26 |
24 |
$0.00 |